Mitochondrial priming in therapy-induced senescence: implications for CAR-T/NK immunosenolytic therapy
Therapy-induced senescence (TIS) generates an immunogenic state in cancer cells by altering how they present antigens, produce cytokines, and organize their surfaceome. TIS can be exploited for therapeutic purposes using “immunosenolytic” strategies, i…